Select status:
Sort by:
Filter by expected publication date

Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and July 2025

Filter by type
Showing 1 to 10 of 659
Title Type Expected publication date
Axitinib, everolimus, sorafenib and sunitinib for treated advanced or metastatic renal cell carcinoma [ID897] Technology appraisal guidance Expected publication date:TBC 0
A4250 for treating progressive familial intrahepatic cholestasis [ID1570] Highly specialised technology Expected publication date:TBC 0
Abemaciclib for treating KRAS mutation-positive non-small-cell lung cancer after platinum-based chemotherapy ID1147 Technology appraisal guidance Expected publication date:TBC 0
Abemaciclib monotherapy for treating advanced hormone-receptor positive, HER2-negative breast cancer after endocrine therapy and chemotherapy ID1347 Technology appraisal guidance Expected publication date:TBC 0
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy [ID2727] Technology appraisal guidance Expected publication date:17 March 2021 20210317
Abiraterone for treating newly diagnosed high risk metastatic hormone-naive prostate cancer [ID945] Technology appraisal guidance Expected publication date:29 July 2020 20200729
Abortion care Quality standard Expected publication date:TBC 0
Acalabrutinib for untreated and treated chronic lymphocytic leukaemia [ID1613] Technology appraisal guidance Expected publication date:TBC 0
Acne Vulgaris: Management NICE guideline Expected publication date:TBC 0
Acute coronary syndromes NICE guideline Expected publication date:TBC 0